These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10682024)

  • 21. Prevalence of vancomycin resistant enterococci on poultry farms established after the ban of avoparcin.
    Sørum M; Holstad G; Lillehaug A; Kruse H
    Avian Dis; 2004 Dec; 48(4):823-8. PubMed ID: 15666863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of vancomycin-resistant enterococci from supermarket poultry.
    Kirk M; Hill RL; Casewell MW; Beighton D
    Adv Exp Med Biol; 1997; 418():289-91. PubMed ID: 9331655
    [No Abstract]   [Full Text] [Related]  

  • 23. Study of vancomycin resistance in faecal enterococci from healthy humans and dogs in Spain a decade after the avoparcin ban in Europe.
    López M; Tenorio C; Torres C
    Zoonoses Public Health; 2013 Mar; 60(2):160-7. PubMed ID: 22646722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of banning avoparcin on VRE carriage in The Netherlands.
    van den Bogaard AE; Bruinsma N; Stobberingh EE
    J Antimicrob Chemother; 2000 Jul; 46(1):146-8. PubMed ID: 10882707
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence, persistence, and molecular characterization of glycopeptide-resistant enterococci in Norwegian poultry and poultry farmers 3 to 8 years after the ban on avoparcin.
    Sørum M; Johnsen PJ; Aasnes B; Rosvoll T; Kruse H; Sundsfjord A; Simonsen GS
    Appl Environ Microbiol; 2006 Jan; 72(1):516-21. PubMed ID: 16391086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First characterization of vancomycin-resistant enterococci from a Portuguese hospital.
    Novais C; Vital C; Ribeiro G; Coque TM; Peixe LV
    J Antimicrob Chemother; 2002 Jan; 49(1):215-7. PubMed ID: 11751793
    [No Abstract]   [Full Text] [Related]  

  • 27. Antimicrobial growth promoter ban and resistance to macrolides and vancomycin in enterococci from pigs.
    Boerlin P; Wissing A; Aarestrup FM; Frey J; Nicolet J
    J Clin Microbiol; 2001 Nov; 39(11):4193-5. PubMed ID: 11682559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuing occurrence of vancomycin resistance determinants in Danish pig farms 20 years after removing exposure to avoparcin.
    Birkegård AC; Græsbøll K; Clasen J; Halasa T; Toft N; Folkesson A
    Vet Microbiol; 2019 May; 232():84-88. PubMed ID: 31030850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry.
    Klare I; Badstübner D; Konstabel C; Böhme G; Claus H; Witte W
    Microb Drug Resist; 1999; 5(1):45-52. PubMed ID: 10332721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
    Sweeney D; Stoneburner A; Shinabarger DL; Arhin FF; Belley A; Moeck G; Pillar CM
    J Antimicrob Chemother; 2017 Feb; 72(2):622-624. PubMed ID: 27856721
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of banning vancomycin analogue avoparcin on vancomycin-resistant enterococci in chicken farms in Taiwan.
    Lauderdale TL; Shiau YR; Wang HY; Lai JF; Huang IW; Chen PC; Chen HY; Lai SS; Liu YF; Ho M
    Environ Microbiol; 2007 Mar; 9(3):819-23. PubMed ID: 17298380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enterococci and vancomycin resistance.
    French GL
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S75-83. PubMed ID: 9710674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.
    McDonald LC; Kuehnert MJ; Tenover FC; Jarvis WR
    Emerg Infect Dis; 1997; 3(3):311-7. PubMed ID: 9284375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycopeptide carboxamides active against vancomycin-resistant enterococci.
    Zweifel MJ; Snyder NJ; Cooper RD; Nicas TI; Mullen DL; Butler TF; Rodriguez MJ
    J Antibiot (Tokyo); 2003 Mar; 56(3):289-95. PubMed ID: 12760685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycopeptide-resistant enterococci: a decade of experience.
    Woodford N
    J Med Microbiol; 1998 Oct; 47(10):849-62. PubMed ID: 9788808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides.
    Cercenado E; Cercenado S; Gómez JA; Bouza E
    J Antimicrob Chemother; 2003 Jul; 52(1):138-9. PubMed ID: 12805264
    [No Abstract]   [Full Text] [Related]  

  • 37. Occurrence of the vancomycin-resistant genes vanA, vanB, vanCl, vanC2 and vanC3 in Enterococcus strains isolated from poultry and pork.
    Lemcke R; Bülte M
    Int J Food Microbiol; 2000 Sep; 60(2-3):185-94. PubMed ID: 11016608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin resistant enterococci (VRE) still persist in slaughtered poultry in hungary 8 years after the ban on avoparcin.
    Ghidán A; Dobay O; Kaszanyitzky EJ; Samu P; Amyes SG; Nagy K; Rozgonyi F
    Acta Microbiol Immunol Hung; 2008 Dec; 55(4):409-17. PubMed ID: 19130748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin-resistant enterococci: mechanisms and clinical observations.
    Gold HS
    Clin Infect Dis; 2001 Jul; 33(2):210-9. PubMed ID: 11418881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms.
    Simonsen GS; Haaheim H; Dahl KH; Kruse H; Løvseth A; Olsvik O; Sundsfjord A
    Microb Drug Resist; 1998; 4(4):313-8. PubMed ID: 9988050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.